Seventure Partners
Seventure Partners is a European venture capital firm founded in 1997 and based in Paris, with €1 billion under management as of June 2024. It actively funds innovative companies in the fields of Digital technologies and Life sciences, supporting their growth and contributing to economic development in Europe.
AUM
€704M
Funds
9
vintages 2007–2022
Portfolio
126
Exits
10
Key facts
Recent exits
365Talents
HR Tech2026 · 7yr hold
Saagie
Business Services2025 · 5yr hold
Wealthpilot
Fintech2025 · 5yr hold
DayTwo
Biotech2024 · 7yr hold
Coverage notes
9 funds tracked, 136 portfolio companies (126 active · 10 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
134 companiesBiotech
42 · 31%
MedTech
17 · 13%
Fintech
16 · 12%
Consumer
15 · 11%
Business Services
12 · 9%
E-commerce
7 · 5%
Healthcare
7 · 5%
Energy
5 · 4%
Funds & portfolio
Every fund Seventure Partners has raised, with its portfolio companies. Hand-checked from public filings.
9 funds
Blue Forward FundGrowth2022 · 4yr€130M11 active
Unrealized
11 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Energy |  France | 2023 | |
| Energy | France | 2020 | |
| Energy | France | 2023 | |
| Consumer | France | 2022 | |
| Energy | Canada | 2022 | |
| Energy |  Netherlands | 2022 | |
| ClimateTech | France | 2022 | |
| ClimateTech | France | 2023 | |
| ClimateTech | France | 2022 | |
| ClimateTech | France | 2025 | |
| ClimateTech | France | 2026 |
ChemdocActive
EnergyFrance· Entry 2023
France· Entry 2023Dielen LaboratoireActive
EnergyFrance· Entry 2020
France· Entry 2020Eauzons!Active
EnergyFrance· Entry 2023
France· Entry 2023FreeJump SystemActive
ConsumerFrance· Entry 2022
France· Entry 2022GITActive
EnergyCanada· Entry 2022
GOA VenturesActive
EnergyNetherlands· Entry 2022
Netherlands· Entry 2022InalveActive
ClimateTechFrance· Entry 2022
France· Entry 2022Seaweed ConceptActive
ClimateTechFrance· Entry 2023
France· Entry 2023SinayActive
ClimateTechFrance· Entry 2022
France· Entry 2022SyrocoActive
ClimateTechFrance· Entry 2025
France· Entry 2025vorteX-ioActive
ClimateTechFrance· Entry 2026
France· Entry 2026Digital Opportunities Fund IIVC2020 · 6yr€80M9 active · 1 realized
Unrealized
9 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Fintech | France | 2022 | |
| E-commerce | France | 2023 | |
| Fintech |  Germany | 2026 | |
| E-commerce | France | 2026 | |
| Fintech | France | 2021 | |
| E-commerce | France | 2020 | |
| Business Services | France | 2023 | |
| E-commerce | France | 2026 | |
| Business Services | France | 2023 |
CitalidActive
FintechFrance· Entry 2022
France· Entry 2022GlopalActive
E-commerceFrance· Entry 2023
France· Entry 2023IdnowActive
FintechGermany· Entry 2026
Germany· Entry 2026MediadsActive
E-commerceFrance· Entry 2026
France· Entry 2026OpencellActive
FintechFrance· Entry 2021
France· Entry 2021OtoqiActive
E-commerceFrance· Entry 2020
France· Entry 2020PitchyActive
Business ServicesFrance· Entry 2023
France· Entry 2023ReelevantActive
E-commerceFrance· Entry 2026
France· Entry 2026WallixActive
Business ServicesFrance· Entry 2023
France· Entry 2023Health for Life Capital IIVC2020 · 6yr€200M6 active
Unrealized
6 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Biotech | France | 2023 | |
| Biotech |  US | 2023 | |
| Biotech | Inde | 2023 | |
| Healthcare | France | 2020 | |
| Biotech | Germany | 2021 | |
| Biotech |  Belgium | 2023 |
NanobiotixActive
BiotechFrance· Entry 2023
France· Entry 2023RevivBioActive
BiotechUS· Entry 2023
US· Entry 2023String BIOActive
BiotechInde· Entry 2023
TibotActive
HealthcareFrance· Entry 2020
France· Entry 2020TubulisActive
BiotechGermany· Entry 2021
Germany· Entry 2021VirovetActive
BiotechBelgium· Entry 2023
Belgium· Entry 2023Sport & Performance CapitalVC2019 · 7yr€80M17 active
Unrealized
17 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Hospitality | France | 2025 | |
| Consumer | France | 2023 | |
| Consumer | France | 2023 | |
| Consumer | France | 2020 | |
| Consumer | France | 2025 | |
| Consumer | France | 2024 | |
| Consumer | France | 2022 | |
| Consumer | France | 2022 | |
| Consumer | France | 2019 | |
| Biotech | US | 2020 | |
| Fintech | France | 2022 | |
| Consumer | France | 2019 | |
| Consumer | France | 2019 | |
| Consumer | France | 2020 | |
| Consumer | France | 2019 | |
| Consumer | France | 2022 | |
| Consumer | Finlande | 2026 |
AnybuddyActive
HospitalityFrance· Entry 2025
France· Entry 2025BaouwActive
ConsumerFrance· Entry 2023
France· Entry 2023bsportActive
ConsumerFrance· Entry 2023
France· Entry 2023Clim8Active
ConsumerFrance· Entry 2020
France· Entry 2020EkstereActive
ConsumerFrance· Entry 2025
France· Entry 2025ExoActive
ConsumerFrance· Entry 2024
France· Entry 2024FreejumpActive
ConsumerFrance· Entry 2022
France· Entry 2022GeoveloActive
ConsumerFrance· Entry 2022
France· Entry 2022HardloopActive
ConsumerFrance· Entry 2019
France· Entry 2019KariusActive
BiotechUS· Entry 2020
US· Entry 2020KarmenActive
FintechFrance· Entry 2022
France· Entry 2022KinomapActive
ConsumerFrance· Entry 2019
France· Entry 2019Move’n SeeActive
ConsumerFrance· Entry 2019
France· Entry 2019SkillcornerActive
ConsumerFrance· Entry 2020
France· Entry 2020SportEasyActive
ConsumerFrance· Entry 2019
France· Entry 2019The Sancturary GroupActive
ConsumerFrance· Entry 2022
France· Entry 2022ZennizActive
ConsumerFinlande· Entry 2026
AVF FundVC2018 · 8yr€24M1 active
Digital Opportunities FundVC2017 · 9yr€56M20 active · 3 realized
Unrealized
20 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Fintech | France | 2020 | |
| Fintech | Germany | 2020 | |
| Business Services | France | 2022 | |
| Fintech | Germany | 2020 | |
| Business Services | France | 2013 | |
| Fintech | France | 2022 | |
| Healthcare | Israel | 2022 | |
| Fintech | France | 2020 | |
| HR Tech | France | 2018 | |
| E-commerce | France | 2019 | |
| – | – | – | |
| Business Services | France | 2022 | |
| Fintech | France | 2021 | |
| Business Services | France | 2020 | |
| Business Services | France | 2021 | |
| E-commerce | Germany | 2021 | |
| Fintech | France | 2022 | |
| Fintech | Germany | 2019 | |
| Fintech |  UK | 2019 | |
| Business Services | France | 2021 |
Aston Itrade FinanceActive
FintechFrance· Entry 2020
France· Entry 2020FlexvelopActive
FintechGermany· Entry 2020
Germany· Entry 2020HackuityActive
Business ServicesFrance· Entry 2022
France· Entry 2022HepsterActive
FintechGermany· Entry 2020
Germany· Entry 2020HomerezActive
Business ServicesFrance· Entry 2013
France· Entry 2013IdeelActive
FintechFrance· Entry 2022
France· Entry 2022InspectoActive
HealthcareIsrael· Entry 2022
IzicapActive
FintechFrance· Entry 2020
France· Entry 2020JobteaserActive
HR TechFrance· Entry 2018
France· Entry 2018JolimoiActive
E-commerceFrance· Entry 2019
France· Entry 2019LaunchmetricsActive
Own SecurityActive
Business ServicesFrance· Entry 2022
France· Entry 2022Rejolt (ex Business...Active
FintechFrance· Entry 2021
France· Entry 2021Secure-ICActive
Business ServicesFrance· Entry 2020
France· Entry 2020Sekoia.ioActive
Business ServicesFrance· Entry 2021
France· Entry 2021SentrycActive
E-commerceGermany· Entry 2021
Germany· Entry 2021SiitActive
FintechFrance· Entry 2022
France· Entry 2022SumupActive
FintechGermany· Entry 2019
Germany· Entry 2019TransferGoActive
FintechUK· Entry 2019
UK· Entry 2019YesWeHackActive
Business ServicesFrance· Entry 2021
France· Entry 2021Realized
3 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| HR Tech | France | 2019 | 2026 | Trade Sale | – | ||
| Fintech | France | 2018 | 2023 | Trade Sale | – | ||
| Fintech | Germany | 2020 | 2025 | Trade Sale | – |
Health for Life CapitalVC2014 · 12yr€160M53 active · 3 realized
Unrealized
53 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Biotech | Germany | 2021 | |
| Biotech | France | 2022 | |
| Biotech | Japan | 2021 | |
| Biotech | Israel | 2017 | |
| MedTech | Germany | 2019 | |
| Healthcare |  Ireland | 2021 | |
| Biotech | Netherlands | 2021 | |
| – | – | – | |
| Biotech |  Denmark | 2023 | |
| Biotech | Belgium | 2021 | |
| MedTech | France | 2019 | |
| Biotech | Denmark | 2023 | |
| Biotech | US | 2020 | |
| MedTech | Germany | 2020 | |
| Healthcare | US | 2021 | |
| Biotech | France | 2019 | |
| Biotech | France | 2016 | |
| Biotech | France | 2022 | |
| Biotech | US | 2022 | |
| Biotech | US | 2021 | |
| MedTech | France | 2016 | |
| Healthcare | Canada | 2026 | |
| Healthcare | France | 2023 | |
| Biotech |  Norway | 2022 | |
| Biotech | France | 2022 | |
| Biotech | US | 2020 | |
| Business Services | Germany | 2020 | |
| Biotech | France | 2026 | |
| Biotech | Germany | 2018 | |
| MedTech | Ireland | 2022 | |
| MedTech | France | 2015 | |
| MedTech | Netherlands | 2019 | |
| Pharma | France | 2017 | |
| Biotech | UK | 2026 | |
| Biotech | US | 2020 | |
| Telecom | France | 2016 | |
| Biotech | Canada | 2023 | |
| Biotech | Canada | 2022 | |
| Biotech | US | 2022 | |
| Biotech | Singapore | 2023 | |
| Biotech | Poland | 2022 | |
| MedTech | France | 2016 | |
| MedTech | UK | 2023 | |
| FoodTech |  Spain | 2023 | |
| Biotech | US | 2020 | |
| Biotech | France | 2026 | |
| Biotech | France | 2023 | |
| MedTech | Belgium | 2024 | |
| Biotech | France | 2019 | |
| Business Services | Germany | 2018 | |
| Biotech | Belgium | 2020 | |
| Biotech | US | 2020 | |
| Biotech | US | 2023 |
AbalosActive
BiotechGermany· Entry 2021
Germany· Entry 2021AllozymesActive
BiotechFrance· Entry 2022
France· Entry 2022AnaeropharmaActive
BiotechJapan· Entry 2021
BiomXActive
BiotechIsrael· Entry 2017
CardioSecurActive
MedTechGermany· Entry 2019
Germany· Entry 2019CattleEyeActive
HealthcareIreland· Entry 2021
Ireland· Entry 2021CitryllActive
BiotechNetherlands· Entry 2021
Netherlands· Entry 2021Clinical MicrobiomicsActive
Cmbio –...Active
BiotechDenmark· Entry 2023
Denmark· Entry 2023Corpowell (Vecollal)Active
BiotechBelgium· Entry 2021
Belgium· Entry 2021CorWaveActive
MedTechFrance· Entry 2019
France· Entry 2019CytokiActive
BiotechDenmark· Entry 2023
Denmark· Entry 2023DermalaActive
BiotechUS· Entry 2020
US· Entry 2020DopavisionActive
MedTechGermany· Entry 2020
Germany· Entry 2020EctoActive
HealthcareUS· Entry 2021
US· Entry 2021EligoActive
BiotechFrance· Entry 2019
France· Entry 2019EnteromeActive
BiotechFrance· Entry 2016
France· Entry 2016ErvimmuneActive
BiotechFrance· Entry 2022
France· Entry 2022Federation BioActive
BiotechUS· Entry 2022
US· Entry 2022FoodsmartActive
BiotechUS· Entry 2021
US· Entry 2021Impeto MedicalActive
MedTechFrance· Entry 2016
France· Entry 2016Kainova TherapeuticsActive
HealthcareCanada· Entry 2026
KapseraActive
HealthcareFrance· Entry 2023
France· Entry 2023KebonyActive
BiotechNorway· Entry 2022
Norway· Entry 2022La VieActive
BiotechFrance· Entry 2022
France· Entry 2022LarqActive
BiotechUS· Entry 2020
US· Entry 2020LecturioActive
Business ServicesGermany· Entry 2020
Germany· Entry 2020MaaT PharmaActive
BiotechFrance· Entry 2026
France· Entry 2026MachtfitActive
BiotechGermany· Entry 2018
Germany· Entry 2018MainstayActive
MedTechIreland· Entry 2022
Ireland· Entry 2022Mauna KeaActive
MedTechFrance· Entry 2015
France· Entry 2015MedEyeActive
MedTechNetherlands· Entry 2019
Netherlands· Entry 2019MedinCellActive
PharmaFrance· Entry 2017
France· Entry 2017MicrobioticaActive
BiotechUK· Entry 2026
UK· Entry 2026Myco TechnologyActive
BiotechUS· Entry 2020
US· Entry 2020NexessActive
TelecomFrance· Entry 2016
France· Entry 2016Nimble SciencesActive
BiotechCanada· Entry 2023
NovobindActive
BiotechCanada· Entry 2022
One Bio ex BCD...Active
BiotechUS· Entry 2022
US· Entry 2022PeptobioticsActive
BiotechSingapore· Entry 2023
Proteon...Active
BiotechPoland· Entry 2022
ProtipActive
MedTechFrance· Entry 2016
France· Entry 2016QuantaActive
MedTechUK· Entry 2023
UK· Entry 2023SequentiaActive
FoodTechSpain· Entry 2023
Spain· Entry 2023Siolta TherapeuticsActive
BiotechUS· Entry 2020
US· Entry 2020Standing OvationActive
BiotechFrance· Entry 2026
France· Entry 2026StarfishActive
BiotechFrance· Entry 2023
France· Entry 2023SunriseActive
MedTechBelgium· Entry 2024
Belgium· Entry 2024TargedysActive
BiotechFrance· Entry 2019
France· Entry 2019TestbirdsActive
Business ServicesGermany· Entry 2018
Germany· Entry 2018The Akkermansia...Active
BiotechBelgium· Entry 2020
Belgium· Entry 2020VedantaActive
BiotechUS· Entry 2020
US· Entry 2020Vertero...Active
BiotechUS· Entry 2023
US· Entry 2023
Quadrivium 1 Seed FundVC2013 · 13yr€56M8 active · 1 realized
Unrealized
8 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| MedTech | Denmark | 2018 | |
| Fintech | France | 2020 | |
| Business Services | France | 2021 | |
| E-commerce | France | 2022 | |
| MedTech | France | 2018 | |
| MedTech | UK | 2021 | |
| Biotech | Denmark | 2018 | |
| MedTech | Germany | 2019 |
AcarixActive
MedTechDenmark· Entry 2018
Denmark· Entry 2018AlgoanActive
FintechFrance· Entry 2020
France· Entry 2020ArtifaktActive
Business ServicesFrance· Entry 2021
France· Entry 2021DashbookActive
E-commerceFrance· Entry 2022
France· Entry 2022FeetmeActive
MedTechFrance· Entry 2018
France· Entry 2018Fire1Active
MedTechUK· Entry 2021
UK· Entry 2021Galecto BiotechActive
BiotechDenmark· Entry 2018
Denmark· Entry 2018HumedicsActive
MedTechGermany· Entry 2019
Germany· Entry 2019Realized
1 exit| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| MedTech | France | 2016 | 2019 | Trade Sale | – |
Spef Pre-IPOVC2007 · 19yr€30M1 active
Track Seventure Partners
Saved GPs appear in your watchlist, one click from your workspace.
About Seventure Partners
Seventure Partners is a European venture capital firm with €1 billion of assets under management as of June 2024, founded in 1997 and headquartered in Paris. The firm specialises in Digital and Life Sciences themes with global recognition as a leading microbiome-focused investor through dedicated themed funds. Seventure operates as part of Natixis Investment Managers within the broader Groupe BPCE financial group.
Investment thesis
Seventure deploys venture capital across two complementary themes: Digital (enterprise software, fintech, digital media) and Life Sciences (biotech, MedTech, HealthTech with particular depth in microbiome and nutrition themes). Investment stages span early-stage seed and Series A through growth equity commitments. The microbiome thematic franchise distinguishes Seventure as one of the few European VCs with dedicated capital for that emerging scientific vertical, with equity tickets typically ranging from €1 million to €15 million per transaction.
Recent activity
Recent realised exits include 365Talents (business services, 2026), Saagie (business services, 2025), Medius Expensya (fintech, 2023) and Polaris (biotech, 2023), reflecting active distribution across the technology and life sciences franchises. The platform tracks 10 funds and 126 active portfolio companies across the multi-decade European VC programme. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
Breega
France·€700M
Vivalto Partners
France·€700M
360 Capital Partners
France·€700M
La Maison Partners
France·€700M
GENEO Capital Entrepreneur
France·€740M
Sparring Capital
France·€650M
Essling Capital
France·€650M
M Capital
France·€635M
Lauxera Capital Partners
France·€780M
Singular Capital Partners
France·€625M
Supernova Invest
France·€800M
Indigo Capital
France·€800MGet the full picture on Seventure Partners.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Save this GP to your watchlist
Saved searches that re-run your sourcing filters in one click
Geography breakdown across 17 geographies
Exit buyers and MOIC on every realized deal (Pro)
Export, compare GPs side by side (Pro)
Already a member? Sign in
Look up another firm or company
Last updated August 2026 · Sourced from public filings · Report an issue